TY - JOUR
T1 - Five-membered heteroaromatic ring fused-pyrimidine derivatives
T2 - Design, synthesis, and hedgehog signaling pathway inhibition study
AU - Zhang, Liandi
AU - Xin, Minhang
AU - Shen, Han
AU - Wen, Jun
AU - Tang, Feng
AU - Tu, Chongxing
AU - Zhao, Xinge
AU - Wei, Ping
PY - 2014/8/1
Y1 - 2014/8/1
N2 - A series of novel five-membered heteroaromatic ring fused-pyrimidine derivatives including purines, pyrrolo[2,3-d]pyrimidines, pyrrolo[3,2-d] pyrimidines, thieno[2,3-d]pyrimidines, thieno[3,2-d]pyrimidines and furo[3,2-d]pyrimidines have been identified to be potent inhibitors of hedgehog signaling pathway. The synthesis and SAR of these compounds are described. Among this new series of hedgehog signaling pathway inhibitors, most compounds exhibited significant inhibitory activity compared to vismodegib, indicating that the five-membered heteroaromatic ring fused-pyrimidines stand out as encouraging scaffolds among the currently reported structural skeletons for hedgehog signaling pathway inhibitors, deserving more exploration and further investigation.
AB - A series of novel five-membered heteroaromatic ring fused-pyrimidine derivatives including purines, pyrrolo[2,3-d]pyrimidines, pyrrolo[3,2-d] pyrimidines, thieno[2,3-d]pyrimidines, thieno[3,2-d]pyrimidines and furo[3,2-d]pyrimidines have been identified to be potent inhibitors of hedgehog signaling pathway. The synthesis and SAR of these compounds are described. Among this new series of hedgehog signaling pathway inhibitors, most compounds exhibited significant inhibitory activity compared to vismodegib, indicating that the five-membered heteroaromatic ring fused-pyrimidines stand out as encouraging scaffolds among the currently reported structural skeletons for hedgehog signaling pathway inhibitors, deserving more exploration and further investigation.
KW - Five-membered heteroaromatic ring fused-pyrimidine
KW - Hedgehog signaling pathway
KW - Inhibitors
KW - Synthesis
UR - http://www.scopus.com/inward/record.url?scp=84904060981&partnerID=8YFLogxK
U2 - 10.1016/j.bmcl.2014.05.066
DO - 10.1016/j.bmcl.2014.05.066
M3 - 文章
C2 - 24923765
AN - SCOPUS:84904060981
SN - 0960-894X
VL - 24
SP - 3486
EP - 3492
JO - Bioorganic and Medicinal Chemistry Letters
JF - Bioorganic and Medicinal Chemistry Letters
IS - 15
ER -